Literature DB >> 22396914

Antimicrobial and Safety Properties of Lactobacilli Isolated from two Cameroonian Traditional Fermented Foods.

Pierre Marie Kaktcham1, Ngoufack François Zambou, Félicité Mbiapo Tchouanguep, Morsi El-Soda, Muhammad Iqbal Choudhary.   

Abstract

Twenty-one Lactobacillus isolates from "Sha'a" (a maize - based fermented beverage) and "Kossam" (traditionally fermented cow milk) were selected in accordance with their antagonistic activities and tested for their bacteriocinogenic potential as well as safety properties. These isolates were preliminarily identified as Lactobacillus plantarum (62%), Lactobacillus rhamnosus (24%), Lactobacillus fermentum (10%) and Lactobacillus coprophilus (4%) based on phenotypic characteristics and rep-PCR genomic fingerprinting. Twelve (57.1%) out of the 21 strains tested were found to be bacteriocin producers, as revealed by the sensitivity of their antimicrobial substances to proteolytic enzymes (Trypsin, Proteinase K) and inhibition of other Lactobacillus spp. These bacteriocinogenic strains showed no positive haemolytic and gelatinase activities and proved to be sensitive to penicillin G, ampicillin, tetracycline, erythromycin, amoxicillin, chloramphenicol, co-trimoxazole and doxycyclin, but resistant to ciprofloxacin and gentamicin. The bacteriocins showed a broad inhibitory activity against Gram-positive and Gram-negative pathogenic bacteria, several of which are classified as especially dangerous by the World Health Organization, as well as Multidrug-resistant strains. These include Staphylococcus aureus, Salmonella enterica subsp. enterica serovare Typhi, Bacillus cereus, Streptococcus mutans, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae and Shigella flexneri. These Lactobacillus strains are promising candidates for use as protective cultures in food fermentation.

Entities:  

Keywords:  Antimicrobial activity; Kossam; Lactobacillus spp.; Rep-PCR; Safety properties; Sha’a

Year:  2011        PMID: 22396914      PMCID: PMC3293358          DOI: 10.3797/scipharm.1107-12

Source DB:  PubMed          Journal:  Sci Pharm        ISSN: 0036-8709


Introduction

Lactic acid bacteria (LAB) have been used in the processing of fermented foods for centuries [1]. They are part of the daily diet of virtually all people around the world. Most often, production of indigenous fermented foods depends on naturally occurring LAB. They have the ability to produce a variety of antimicrobial substances such as organic acids, hydrogen peroxide and bacteriocins. Bacteriocins produced by LAB are ribosomally synthesized extracellular small peptides that exhibit bactericidal or bacteriostatic activity against genetically closely related bacteria [2]. They are the most important, because, due to their proteinaceous nature, they are rapidly digested by proteases in human and animal gastrointestinal tracts, unlike current antibiotics [3]. Given that the prevalence of multidrug-resistant (MDR) and especially dangerous pathogenic bacteria is increasing at an alarming rate [4], bacteriocins or bacteriocin-like substances could be a novel approach for an effective drug. In addition, fermented foods are also associated with LAB which possess remarkable properties for their use as starter cultures or probiotics. They are usually used for their health benefits in animal or human, and it is recommended that antibiotic resistance patterns and opportunistic virulence properties should be tested to document their safety [5]. In fact, antibiotic-resistant LAB could horizontally transfer their genes or determinants to opportunistic pathogens within the gut microbiota [6]. In the western highlands region of Cameroon, two traditional fermented foods named “Kossam” (fermented cow milk) and “Sha’a” (a maize-based beverage) are widely produced and consumed. While they constitute a natural reservoir of LAB which have not yet been identified and studied for their antimicrobial activity, there is obvious evidence that LAB strains from different origins could possess antimicrobial activities at different levels. It became important to initiate comprehensive studies to screen antimicrobial and safety properties of the wild LAB microbiota from these natural reservoirs for their antimicrobial applications. This research is important in order to valorise indigenous strains and also to propose another alternative to satisfy the increasing request of the market with novel bacteriocinogenic characterized LAB strains. In the present study, lactobacilli with antagonistic activity isolated from “Kossam” and “Sha’a” were characterized and identified. They were also evaluated for bacteriocin production as well as some safety properties such as antibiotic susceptibility, haemolysis and gelatinase activities.

Results and Discussion

Isolation of Lactobacillus strains and inhibitory activity

A total of 90 Lactobacillus isolates was obtained. Sixty (75%) out of the 90 isolates inhibited the growth of the other lactobacilli strains, as well as Staphylococcus aureus ATCC25923, Salmonella enterica subsp. enterica serovare Typhi ATCC6539, Pseudomonas aeruginosa ATCC27853, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Shigella flexneri. From these 60 isolates, 21 (35%) with largest spectra and zone of inhibition were selected and used for further assays.

Preliminary identification of strains

The microscopic examination reveals that the tested isolates have cellular rod form, associated in pairs, heap or chain. In addition, all the isolates were found to be gram-positive and catalase-negative. Based on the fermentative profile, data from each isolate was compared with profiles obtained from recognized test organisms, and it was determined that the isolates can be classified as Lb. plantarum, Lb. rhamnosus, Lb. coprophilus and Lb. fermentum (Table 1).
Tab. 1

Comparison of the identification of Lactobacilli isolates using API system and rep-PCR profiles.

IsolatesIdentification by API system (% similarity)Identification by rep-PCR (% identity)
1SLactobacillus plantarum (99.9%)Lactobacillus plantarum (72.5%)
2SLactobacillus plantarum (99.9%)Lactobacillus plantarum (80.0%)
3SLactobacillus plantarum (99.9%)Lactobacillus plantarum (75.8%)
4SLactobacillus plantarum (75.9%)Lactobacillus plantarum (74.6%)
5SLactobacillus plantarum (99.9%)Lactobacillus plantarum (74.9%)
6SLactobacillus plantarum (99.9%)Lactobacillus plantarum (74.5%)
7SLactobacillus plantarum (99.9%)Lactobacillus plantarum (72.6%)
8SLactobacillus plantarum (99.9%)Lactobacillus plantarum (73.0%)
9SLactobacillus plantarum (72.0%)Lactobacillus plantarum (72.9%)
10SLactobacillus plantarum (79.0%)Lactobacillus plantarum (73.9%)
11SLactobacillus plantarum (77.0%)Lactobacillus plantarum (73.6%)
15SLactobacillus plantarum (85.9%)Lactobacillus plantarum (65.8%)
16SLactobacillus plantarum (89.9%)Lactobacillus plantarum (65.7%)
18SLactobacillus rhamnosus (97.5%)Unidentified
19SLactobacillus rhamnosus (86.0%)Unidentified
1KLactobacillus rhamnosus (86.0%)Lactobacillus rhamnosus (73.1%)
3KLactobacillus rhamnosus (88.5%)Lactobacillus rhamnosus (65.0%)
1K1Lactobacillus rhamnosus (96.5%)Lactobacillus rhamnosus (70.4%)
2KLactobacillus fermentum (74.1%)Lactobacillus fermentum (69.2%)
13S*Lactobacillus coprophilus (77.0%)Lactobacillus fermentum (68.4%)
1SB1Lactobacillus coprophilus (97.0%)unidentified

…API result does not match with rep-PCR identification in this case.

From the 21 isolates tested and identified using phenotypic characteristics, 18 were identified by rep-PCR. The dendrogram generated from BOXA1R-PCR banding patterns are given in Figure 1. The isolates belonging to group II Lactobacillus spp. were classified into 2 clusters. Cluster 1 consisted of Lb. rhamnosus (1K, 1K1, 3K) at r = 69.5%, whereas cluster 2 grouped Lb. plantarum strains (1S, 2S, 3S, 4S, 5S, 6S, 7S, 8S, 9S, 10S, 11S, 15S, 16S) at r = 73.06% (Figure 1).
Fig. 1

Dendrograms generated from Box-PCR fingerprinting of the isolated Group II and Group III Lactobacillus spp. The dendrogram was constructed using the unweighted pair group method using arithmetic averages with correlation levels expressed as percentage.

The isolates belonging to the Group III Lactobacillus spp (13S, 2K) were similar to strains of Lb. fermentum at r = 68.8%. The strains of each cluster also showed characteristic banding pattern with slight differences, demonstrating their close relatedness. The majority of Lactobacillus strains with antagonistic activity was found in “Sha’a” where a predominance of Lactobacillus plantarum was observed, whereas in “Kossam”, Lactobacillus rhamnosus was predominant. This result is in accordance with recent investigations showing that LAB with antagonistic activities are largely distributed in cereal-based fermented foods [21, 22]. Rep-PCR confirms all phenotypic results, except for one strain (13S). After identification by API system this strain has higher percent similarity with Lactobacillus coprophilus than Lactobacillus fermentum, but it was identified as Lactobacillus fermentum by rep-PCR. Such situations were also found by authors such as Chagnaud et al. [23], Mohamed et al. [9] and Terzic-Vidojevic et al. [24]. This shows that phenotypic tests sometimes suffer from lack of reproducibility and discriminatory power.

Screening for bacteriocin producing strains

Using combination of Triple-agar layer method and AWDA, 12 (57.1%) out of the 21 strains tested were found to be bacteriocin producers. Complete inactivation was observed when the CFS were treated by proteolytic enzymes, thus confirming the proteinaceous nature of the inhibitory substances. Treatment with α-Amylase and Lipase did not affect the antimicrobial activity, suggesting that the bacteriocins are not attached to carbohydrate or lipid moieties (Table 2 and Figure 2).
Tab. 2

Effect of proteolytic and non-proteolytic enzymes on the activity of cell free supernatants.

Mean Inhibition Zone diameter (mm)a

StrainsControlTrypsinProteinase Kα-AmylaseLipaseLysozyme
Lb. plantarum 2S12.50 (−)0 (−)12 (+)12.5 (+)12.5 (+)
Lb. plantarum 5S13.50 (−)0 (−)13.5 (+)13.5 (+)13.5 (+)
Lb. plantarum 6S160 (−)0 (−)15.5 (+)15.5 (+)16 (+)
Lb. plantarum 7S130 (−)0 (−)12.5 (+)12.5 (+)12.5 (+)
Lb. plantarum 8S12.50 (−)0 (−)12.5 (+)12.5 (+)12.5 (+)
Lb. plantarum 9S130 (−)0 (−)13 (+)13 (+)13 (+)
Lb. pantarum 10S80 (−)0 (−)8 (+)8 (+)8 (+)
Lb. plantarum 11S130 (−)9 (+)13 (+)13 (+)13 (+)
Lb. plantarum 16S120 (−)0 (−)12 (+)12 (+)12 (+)
Lb. rhamnosus 18S120 (−)0 (−)12 (+)12 (+)12 (+)
Lb. rhamnosus 1K140 (−)0 (−)14 (+)14 (+)14 (+)
Lb. fermentum 2K130 (−)0 (−)13 (+)13 (+)13 (+)

…Inhibition zone diameters are means of three assays and include the diameter of the wells (6 mm).

Fig. 2

Antimicrobial activity assessed by halo formation of bacteriocin from strain Lb. plantarum 6S treated with enzymes.

C1: CFS in Tris-HCl buffer, pH 8.0 (untreated).

C: CFS in Phosphate buffer, pH 7.0 (untreated).

T: CFS treated with Trypsin (1 mg/ml).

A: CFS treated with α-Amylase (1 mg/ml).

Li: CFS treated with Lipase (1 mg/ml).

Ly: CFS treated with Lysozyme (1 mg/ml).

Inhibition of sensitive strain of Lactobacillus plantarum confirmed that the inhibitory substances were bacteriocins. This study reports for the first time the characterization of bacteriocin-producing LAB isolated from “Sha’a” and traditionally fermented cow milk from Cameroon. Although many studies reported bacteriocin production by LAB worldwide, few strains of Lactobacillus fermentum were listed [25, 26].

Safety attributes of bacteriocin-producing strains

All 12 strains assayed showed no positive haemolysis and gelatinase activity. With respect to haemolysis activity, these strains were found to be γ-haemolytic. Results of the antibiotic susceptibility of strains are listed in Tables 3 and 4.
Tab. 3

Susceptibility of Lactobacillus strains to antibiotics by disc diffusion test

Inhibition Diameters (mm)a

StrainsAMP10ERY15PEN10CHL30TET30
Lb. plantarum 2S28 (S)30 (S)23 (S)22 (S)22 (S)
Lb. plantarum 5S31 (S)27 (S)22 (S)20 (I)20 (I)
Lb. plantarum 6S30 (S)30 (S)23 (S)25 (S)26 (S)
Lb. plantarum 7S28 (S)30 (S)27 (S)25 (S)23 (S)
Lb. plantarum 8S31 (S)28 (S)30 (S)37 (S)22 (S)
Lb. plantarum 9S34 (S)30 (S)25 (S)25 (S)25 (S)
Lb. plantarum 10S28 (S)26 (S)21 (S)25 (S)20 (I)
Lb. plantarum 11S28 (S)27 (S)22 (S)25 (S)18 (I)
Lb. plantarum 16S27 (S)27 (S)20 (I)27 (S)22 (S)
Lb. rhamnosus 18S35 (S)30 (S)22 (S)27 (S)29 (S)
Lb. rhamnosus 1K35 (S)32 (S)24 (S)22 (S)25 (S)
Lb. fermentum 2K27 (S)28 (S)26 (S)25 (S)21 (S)

Inhibition Diameters (mm)a

GEN30CIP10AMO10COT25DOX30

Lb. plantarum 2S13 (R)13 (R)30 (S)22 (S)21 (S)

Lb. plantarum 5S13 (R)7 (R)30 (S)17 (I)20 (I)

Lb. plantarum 6S11 (R)10 (R)28 (S)20 (I)26 (S)

Lb. plantarum 7S12 (R)12 (R)30 (S)22 (S)22 (S)

Lb. plantarum 8S14 (R)12 (R)28 (S)25 (S)24 (S)

Lb. plantarum 9S22 (S)14 (R)33 (S)20 (I)29 (S)

Lb. plantarum 10S16 (I)7 (R)25 (S)23 (S)23 (S)

Lb. plantarum 11S18 (I)12 (R)26 (S)21 (S)25 S)

Lb. plantarum 16S14 (R)11 (I)28 (S)20 (I)25 (S)

Lb. rhamnosus 18S21 (S)14 (R)32 (S)18 (I)28 (S)

Lb. rhamnosus 1K20 (I)15 (R)29 (S)16 (I)26 (S)

Lb. fermentum 2K16 (I)11 (R)25 (S)24 (S)26 (S)

AMO10: Amoxicillin 10μg; AMP10: Ampicillin 10μg; COT25: Co-trimoxazole (Trimethoprim/Sulfamethoxazole) 1.25+23.75= 25μg; CHL30: Chloramphenicol 30μg; CIP10: Ciprofloxacin 10 μg; DOX30: Doxycyclin 30μg; ERY15: Erythromycin 15μg; PEN10: Penicillin G 10μg; TET30: Tetracycline 30 μg; GEN30: Gentamicin 30μg (CLSI, 2011).

…Inhibition Zone Diameters are means from triplicate determinations; Diameters of the discs are inclusive (6mm); S…Sensitive; I…Intermediate; R…Resistant.

Tab. 4

MIC values (in μg/ml) of antibiotics against Lactobacillus strains.

StrainsAMPPENERYCHLTET

MIC μg/mlMIC BP*MIC μg/mlMIC BP*MIC μg/mlMIC BP*MIC μg/mlMIC BP*MIC μg/mlMIC BP*
Lb. plantarum 2S0.522ND<0.25128832
Lb. plantarum 5S0.522ND<0.25128832
Lb. plantarum 6S0.521ND<0.25128832
Lb. plantarum 7S0.521ND<0.251281632
Lb. plantarum 8S122ND<0.25128832
Lb. plantarum 9S121ND<0.251481632
Lb. plantarum 10S0.521ND<0.25128832
Lb. plantarum 11S0.521ND<0.25148832
Lb. plantarum 16S0.521ND<0.251281632
Lb. rhamnosus 18S0.541ND<0.2512488
Lb. rhamnosus 1K0.542ND<0.25124168
Lb. fermentum 2K0.511ND<0.2512488

GENAMOCIPCOTDOX

MIC μg/mlMIC BP*MIC μg/mlMIC BP*MIC μg/mlMIC BP*MIC μg/mlMIC BP*MIC μg/mlMIC BP*

Lb. plantarum 2S64161ND64ND32ND1ND
Lb. plantarum 5S64160.5ND128ND32ND2ND
Lb. plantarum 6S64161ND64ND32ND2ND
Lb. plantarum 7S64160.5ND64ND64ND4ND
Lb. plantarum 8S64160.5ND64ND64ND4ND
Lb. plantarum 9S64161ND64ND64ND4ND
Lb. plantarum 10S32160.5ND128ND64ND4ND
Lb. plantarum 11S64160.5ND64ND32ND4ND
Lb. plantarum 16S64162ND64ND32ND4ND
Lb. rhamnosus 18S64160.5ND64ND32ND4ND
Lb. rhamnosus 1K64160.5ND64ND64ND4ND
Lb. fermentum 2K64160.5ND64ND64ND2ND

MIC BP = Minimal Inhibitory Concentration Breakpoints, according to European Food Safety Authorities [5]. ND…Not Defined.

Based on the disc diffusion test results, all the strains (100%) were susceptible to inhibitors of the cell wall synthesis (penicillin G, ampicillin and amoxicillin); they were also all susceptible to chloramphenicol and erythromycin. Sixty-six percent showed moderate susceptibility to tetracycline and doxycyclin, whereas 50% were resistant to gentamicin as far as inhibitors of protein or mRNA synthesis were concerned. The strains showed susceptibility (50%) and moderate susceptibility (50%) to co-trimoxazole, but were all resistant (100%) to ciprofloxacin, these antibiotics belonging to the group of nucleic acid synthesis’s inhibitors. With regard to MIC results, the strains showed resistance (100%) only to gentamicin as revealed by the comparison with the EFSA’s breakpoints. According to the ISO’s epidemiological cut-off values, two out of the 10 Lb. plantarum strains were recorded with MICs for ciprofloxacin above the quality control (QC) range. For all the Lb. rhamnosus strains, only the MICs for gentamicin and ciprofloxacin were above the QC range. Safety is one of the recommended attributes in guidelines on evaluation for probiotics and other LAB to be used as food additives [5]. Haemolysis activity would break down the epithelial layer while gelatinase activity would derange the mucoid lining interfering with the normal functioning of these very important linings across which many physiological substances are exchanged and would cause pathways for infections. None of the strains showed haemolysis or gelatinase activity, and these results were in accordance with those of Kalui et al. [27] for Lb. plantarum strains, Lb. rhamnosus strains and Enterococcus faecium ET05. A key requirement for these food additives LAB strains is that they should not carry transferable antibiotic resistance genes. Transferable resistance genes may pose a risk, as they can be transferred to pathogenic bacteria [28]. From the 10 antibiotics tested, some strains were found to be resistant only to two of them, ciprofloxacin and gentamicin. Such cases were also reported by other authors such as Elkins and Mullins, [29]; Herreros et al [30]; Rojo-Bezares et al. [31] who found resistance of Lactobacilli to ciprofloxacin, gentamicin and other aminoglycosides. These resistances are natural and intrinsic resistances, probably due to cell wall structure and membrane impermeability, complemented in some cases by potential efflux mechanisms. Intrinsic resistance is not horizontally transferable and poses no risk in non-pathogenic bacteria [32]. Furthermore, following the EUCAST definition of an epidemiological value [20], our strains can be categorized as wild type organisms (free of acquired and mutational resistance mechanisms). Therefore, all the strains tested in our study are considered to be safe.

Spectrum of Inhibitory activity

The inhibitory spectrum of the bacteriocins produced by selected strains is presented in Table 5.
Tab. 5

Antibacterial spectrum of activity of bacteriocins produced by selected strains.

Bacteriocin Activity of Producer strains

Indicator strainsSourceGrowth conditions2S5S6S7S8S9S10S11S16S18S1K2K
lactic acid bacteria

Lb. plantarum 3SOur isolateMRSc,30°C++++++++++++++++++++++++
Lb. plantarum 9SOur isolateMRS,30°C
Lb. plantarum 29VOur collectionMRS,30°C
Lb. rhamnosus 18SOur isolateMRS,30°C
Lb. rhamnosus 1KOur isolateMRS,30°C
Lb. fermentum 2KOur isolateMRS,30°C
Enterococcus faeciumDSMa 13596BHId,37°C

Gram-positive pathogenic bacteria

Staphylococcus aureusATCC 25923BHI, 37°C++++++++++++++++++++++++
Staphylococcus aureus (MDR)Clinical isolatefBHI, 37°C++++++++++++++++++++++++
Bacillus cereusATCC 11778BHI, 37°C++++++++++++++++++++++++
Streptococcus mutansDSM 20523BHI, 37°C+++++++++++++++++++++++++++++

Gram-negative pathogenic bacteria

Escherichia coliATCC 11775BHI, 37°C+++++++++++++++++++++++++
Escherichia coli (MDR)Clinical isolateBHI, 37°C+++
Salmonella TyphiATCC 6539NBe, 37°C+++++++++++++++++++++++++++++++++++
Pseudomonas aeruginosaATCC 9027BHI, 37°C+++++++++++++++++++++++++++++
Pseudomonas aeruginosaATCC 27853BHI, 37°C++++++++++++++++++++++++
Klebsiella pneumoniaeClinical isolateBHI, 37°C++++++++++++++++++++++++++
Shigella flexneriClinical isolateNB, 37°C+++++++++++++++++++++++++

Inhibition zone Diameter: +++ = >14mm; ++ = 11–14mm; + = 8–10mm; − = no inhibition. MDR: Multidrug-resistant;

DSM: Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany;

ATCC: American Type Culture Collection, Manassas, VA, USA;

de Man, Rogosa and Sharpe;

Brain Heart Infusion;

Nutrient Broth;

Isolates from Centre Pasteur of Yaoundé, Cameroon.

The bacteriocins showed a relatively wide inhibition spectrum, inhibiting the growth of a number of Gram-positive and Gram-negative bacteria including species of the genera Lactobacillus, Streptococcus, Salmonella, Shigella, Bacillus, Staphylococcus, Escherichia, Pseudomonas and Klebsiella. However, no activity was detected against many other Lactobacillus strains and the Enterococcus faecium strain tested. Interestingly, some bacteriocins were active against multidrug-resistant (MDR) strains of S. aureus and E. coli. Multidrug-resistant bacteria have emerged as serious pathogens over the past decade and, despite major research efforts aimed at finding an effective drug, increasing resistance has compromised therapy [33].

Experimental

Samples, bacterial strains and growth conditions

Fifteen and 20 samples respectively of “Kossam” and “Sha’a” were collected directly and aseptically from local producers in three localities of Cameroon’s western highlands region. For lactic acid bacteria isolation, 1% (v/v) of each sample added to MRS broth (de Man Rogosa and Sharpe, Biolife, Milano, Italy) and incubated for 24 h at 30 °C was used to streak the surface of MRS agar plates. The plates were then incubated anaerobically (Genbox anaer; BioMérieux, France) at 30 °C for 48 h. Well-developed individual colonies on these plates were randomly picked and purified on MRS agar. These isolates were characterized based on the morphological characteristics, gram staining and catalase reaction [7]. The lactobacilli strains were kept in MRS broth plus glycerol (70:30) at −20 °C and were subcultured two times in MRS broth for activation prior to experimental use. The reference strains for Rep – PCR analysis were obtained from Institut National de Recherche Agronomique (INRA), Centre de Recherche Zootechnique Jouy – en Josas, France (CNRZ) and American Type Culture Collection (ATCC). Food borne spoilage and pathogenic bacteria (Proteus mirabilis and those listed in Table 5) used as indicator in testing antimicrobial activity were cultured at 37 °C and maintained on Mueller Hinton Agar (MHA, Conda, Madrid, Spain) slants.

Inhibition of the growth of other lactobacilli and pathogenic bacteria

The LAB isolates were tested for inhibition of the growth of other lactobacilli and some pathogenic bacteria using the spot on the lawn test as described by Geis et al. [8]. An aliquot (2 μl) of an overnight LAB culture was spotted onto MRS agar plates and incubated anaerobically at 30 °C for 48 h. The plates were subsequently overlaid with soft MRS agar (0.75% agar) or soft MHA containing 1% indicator strains, respectively, and then incubated anaerobically at 30 °C or aerobically at 37 °C, on the basis of the tested organisms, for 24 h. Only isolates showing the largest inhibition diameter zones were selected for the next steps.

Strains identification using physiological and biochemical methods

The 21 selected isolates were identified to species level using their carbohydrate pattern obtained with API 50 galleries (BioMérieux, Marcy l’Etoile France). Tests were performed according to the manufacturer’s instructions. Interpretations of the fermentation profiles were facilitated by systematically comparing all results obtained from the isolates studied with information from the computer-aided database APILAB plus V.3.2.2.

Rep-PCR genomic fingerprinting

Total DNA was extracted from 1.6 ml of fresh cultures in the exponential growth phase using the Wizard DNA purification Kit as described by the manufacturer (Promega). Amplification of DNA and separation of PCR products were performed according to the method described by Mohammed et al. [9]. The Rep profiles were processed using the Gel Compar version 5.00 software (Applied Maths, Kortrijk, Belgium).

Screening of Lactobacillus strains for bacteriocin production

The Lactobacillus strains were screened for bacteriocin production using the Triple-agar layer method described by Todorov and Dicks [10], with the difference that buffered MRS medium (0.2 M potassium phosphate buffer, pH 7.0) was used and no antibiotic was added. Cell-free supernatants (CFS) of the selected producer strains were screened for bacteriocin activity by the agar well diffusion assay (AWDA) as described by Schillinger and Lücke [11]. A 15-h-old culture (2% v/v) of each lactobacilli strain was inoculated in buffered MRS broth and incubated anaerobically at 30 °C for 10 h. The cultures were centrifuged (7,000 rpm, 30 min, 4 °C) and the supernatants collected, treated at 80 °C for 10 min [12] and then tested for their activity by the AWDA. In another set of experiments, the CFS were incubated for 2 h at 37 °C in the presence of 1.0 mg/ml (final concentration) of Trypsin (in 0.05 M Tris-HCl buffer, pH 8.0, Fluka Biochemika), Proteinase K (in 0.05 M phosphate buffer, pH 7.0, Merck) α-Amylase (in 0.05 M phosphate buffer, pH 7.0, Sigma-Aldrich), Lipase (in 0.05 M phosphate buffer, pH 7.0, Sigma-Aldrich) and Lysozyme (in 0.05 M phosphate buffer, pH 7.0, Fluka Biochemika) and then tested for antimicrobial activity by AWDA. The safety attributes studied were haemolytic activity, gelatinase activity and antibiotic susceptibility. Haemolytic activity was investigated as described by Gerhardt et al. [13]. A 16-hour-old broth culture was streaked onto sterile blood agar plates. Plates were incubated anaerobically at 30 °C for 48 h. The haemolytic reactions were recorded by observation of a clear zone around the colonies (β-haemolysis), a partial hydrolysis and greening zone (α-haemolysis) or no reaction (γ-haemolysis) [14]. Gelatinase activity was investigated as described by Harrigan and Mc Cance [15]. A 16-hour-old culture was streaked onto nutrient gelatin agar (Oxoid). The plates were incubated anaerobically for 48 h at 30 °C after which they were flooded with a saturated ammonium sulfate solution and observed for clear zones surrounding colonies. Antibiotic susceptibility was tested by disk diffusion and by broth micro-dilution methods [16-17], using LSM broth and agar as test media (LSM consists of a mixture of Iso-Sensitest medium, Oxoid Ltd). Incubation was done at 30 °C for 48 h. The MIC (μg/ml) was defined as the lowest antibiotic concentration that resulted in no visible growth. For disc diffusion antibiotic susceptibility, inhibition zone diameters (IZD) were measured and strains were classified as sensitive (IZD ≥ 21mm), intermediate (16mm ≤ IZD ≤ 20mm), and resistant (IZD ≤ 15mm) according to interpretative standards defined by CLSI [18] and Vlková et al. [19]. The MICs (μg/ml) were determined and the results of susceptibility status were interpreted according to the recent FEEDAP document of the European Food Safety Authority (EFSA) on the update of the criteria used in the assessment of antibiotics bacterial resistance of human or veterinary importance [5] as well as epidemiological cutoff values defined by the ACE – ART Project results, ISO 10932 [20]. Strains showing MICs less than EFSA’s breakpoints were considered sensitive; otherwise, they were resistant. The following antibiotics obtained from Oxoid were tested: penicillin G, ampicillin, ciprofloxacin, tetracycline, erythromycin, amoxicillin, gentamicin, chloramphenicol, co-trimoxazole, and doxycyclin.

Spectrum of inhibitory activity of bacteriocin-producing strains

The antibacterial activities of the samples were tested against Gram-positive and Gram-negative bacteria (listed in table 5). The indicator strains (0.5 Mc Farland suspensions) were inoculated in the appropriate soft agar media and the antibacterial activities were determined by AWDA. Experiments were conducted in triplicate.
  16 in total

1.  Antibiotic resistance--the interplay between antibiotic use in animals and human beings.

Authors:  Randall S Singer; Roger Finch; Henrik C Wegener; Robin Bywater; John Walters; Marc Lipsitch
Journal:  Lancet Infect Dis       Date:  2003-01       Impact factor: 25.071

2.  Potential of lactic streptococci to produce bacteriocin.

Authors:  A Geis; J Singh; M Teuber
Journal:  Appl Environ Microbiol       Date:  1983-01       Impact factor: 4.792

3.  Antibacterial activity of Lactobacillus sake isolated from meat.

Authors:  U Schillinger; F K Lücke
Journal:  Appl Environ Microbiol       Date:  1989-08       Impact factor: 4.792

Review 4.  Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.

Authors:  G L French
Journal:  J Antimicrob Chemother       Date:  2006-10-13       Impact factor: 5.790

Review 5.  Potential of using lactic acid bacteria for therapy and immunomodulation in man.

Authors:  P Marteau; J C Rambaud
Journal:  FEMS Microbiol Rev       Date:  1993-09       Impact factor: 16.408

Review 6.  Antibiotic resistance in food lactic acid bacteria--a review.

Authors:  Shalini Mathur; Rameshwar Singh
Journal:  Int J Food Microbiol       Date:  2005-11-08       Impact factor: 5.277

7.  Bile-mediated aminoglycoside sensitivity in Lactobacillus species likely results from increased membrane permeability attributable to cholic acid.

Authors:  Christopher A Elkins; Lisa B Mullis
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

8.  Susceptibility to tetracycline and erythromycin of Lactobacillus paracasei strains isolated from traditional Italian fermented foods.

Authors:  Roberta Comunian; Elisabetta Daga; Ilaria Dupré; Antonio Paba; Chiara Devirgiliis; Valeria Piccioni; Giuditta Perozzi; Daniela Zonenschain; Annalisa Rebecchi; Lorenzo Morelli; Angela De Lorentiis; Giorgio Giraffa
Journal:  Int J Food Microbiol       Date:  2009-12-03       Impact factor: 5.277

9.  Rep-PCR characterization and biochemical selection of lactic acid bacteria isolated from the Delta area of Egypt.

Authors:  Mariam Mohammed; Hossam Abd El-Aziz; Nadia Omran; Shimaa Anwar; Sameh Awad; Morsi El-Soda
Journal:  Int J Food Microbiol       Date:  2008-10-08       Impact factor: 5.277

10.  Bacteriocin production by Lactobacillus plantarum AMA-K isolated from Amasi, a Zimbabwean fermented milk product and study of the adsorption of bacteriocin AMA-K TO Listeria sp.

Authors:  Svetoslav D Todorov
Journal:  Braz J Microbiol       Date:  2008-03-01       Impact factor: 2.476

View more
  10 in total

1.  In Vitro Evaluation of the Probiotic and Safety Properties of Bacteriocinogenic and Non-Bacteriocinogenic Lactic Acid Bacteria from the Intestines of Nile Tilapia and Common Carp for Their Use as Probiotics in Aquaculture.

Authors:  Pierre Marie Kaktcham; Jules-Bocamdé Temgoua; François Ngoufack Zambou; Gloria Diaz-Ruiz; Carmen Wacher; María de Lourdes Pérez-Chabela
Journal:  Probiotics Antimicrob Proteins       Date:  2018-03       Impact factor: 4.609

2.  Characterization of Lactic Acid Bacteria in Raw Buffalo Milk: a Screening for Novel Probiotic Candidates and Their Transcriptional Response to Acid Stress.

Authors:  Gabriela Merker Breyer; Nathasha Noronha Arechavaleta; Franciele Maboni Siqueira; Amanda de Souza da Motta
Journal:  Probiotics Antimicrob Proteins       Date:  2021-04       Impact factor: 4.609

3.  Gardnerella vaginalis and Neisseria gonorrhoeae Are Effectively Inhibited by Lactobacilli with Probiotic Properties Isolated from Brazilian Cupuaçu (Theobroma grandiflorum) Fruit.

Authors:  Nathan das Neves Selis; Hellen Braga Martins de Oliveira; Yan Bento Dos Anjos; Hiago Ferreira Leão; Beatriz Almeida Sampaio; Thiago Macêdo Lopes Correia; Mariane Mares Reis; Thamara Louisy Santos Brito; Carolline Florentino Almeida; Larissa Silva Carvalho Pena; Laís Ferraz Brito; Roberta Maria Ornelas; Tizá Teles Santos; Guilherme Barreto Campos; Jorge Timenetsky; Mariluze Peixoto Cruz; Andréa Miura da Costa; Regiane Yatsuda; Ana Paula Trovatti Uetanabaro; Lucas Miranda Marques
Journal:  Biomed Res Int       Date:  2021-04-29       Impact factor: 3.411

4.  Gamma-aminobutyric acid fermentation in MRS-based medium by the fructophilic Lactiplantibacillus plantarum Y7.

Authors:  Jaegon Kim; Yong-Won Yoon; Min-Sun Kim; Myung-Hyun Lee; Geun-Ah Kim; Kiho Bae; Sung-Sik Yoon
Journal:  Food Sci Biotechnol       Date:  2022-02-08       Impact factor: 2.391

5.  Prevalence of antibiotic resistance in lactic acid bacteria isolated from the faeces of broiler chicken in Malaysia.

Authors:  Nurhazirah Shazali; Hooi Ling Foo; Teck Chwen Loh; Di Wei Choe; Raha Abdul Rahim
Journal:  Gut Pathog       Date:  2014-01-22       Impact factor: 4.181

6.  Safety characterization and antimicrobial properties of kefir-isolated Lactobacillus kefiri.

Authors:  Paula Carasi; Mariángeles Díaz; Silvia M Racedo; Graciela De Antoni; María C Urdaci; María de los Angeles Serradell
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

7.  Indigenous Probiotic Lactobacillus Isolates Presenting Antibiotic like Activity against Human Pathogenic Bacteria.

Authors:  Debashis Halder; Manisha Mandal; Shiv Sekhar Chatterjee; Nishith Kumar Pal; Shyamapada Mandal
Journal:  Biomedicines       Date:  2017-06-16

Review 8.  Co-occurrence of Lactobacillus Species During Fermentation of African Indigenous Foods: Impact on Food Safety and Shelf-Life Extension.

Authors:  Adekemi Titilayo Adesulu-Dahunsi; Samuel Olatunde Dahunsi; Titilayo Adenike Ajayeoba
Journal:  Front Microbiol       Date:  2022-04-07       Impact factor: 6.064

9.  Enterococcus faecium PNC01 isolated from the intestinal mucosa of chicken as an alternative for antibiotics to reduce feed conversion rate in broiler chickens.

Authors:  Yang He; Xuan Liu; Yuanyang Dong; Jiaqi Lei; Koichi Ito; Bingkun Zhang
Journal:  Microb Cell Fact       Date:  2021-06-28       Impact factor: 5.328

10.  Anti-biofilm Properties of the Fecal Probiotic Lactobacilli Against Vibrio spp.

Authors:  Sumanpreet Kaur; Preeti Sharma; Namarta Kalia; Jatinder Singh; Sukhraj Kaur
Journal:  Front Cell Infect Microbiol       Date:  2018-04-24       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.